Published in Nucleic Acids Res on September 11, 1995
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm (2009) 2.81
A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3'-end processing. EMBO Rep (2002) 1.35
Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am J Hum Genet (1996) 1.34
A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06
Oligonucleotide binding specificities of the hnRNP C protein tetramer. Nucleic Acids Res (1998) 1.04
Two-exon skipping within MLPH is associated with coat color dilution in rabbits. PLoS One (2013) 0.77
Identification and Functional Characterization of Two Intronic NIPBL Mutations in Two Patients with Cornelia de Lange Syndrome. Biomed Res Int (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Splicing of messenger RNA precursors. Annu Rev Biochem (1986) 14.41
Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell (1984) 12.30
The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet (1992) 8.20
Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu Rev Cell Biol (1991) 8.14
Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell (1986) 8.06
Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences. Cell (1985) 7.49
Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science (1994) 7.09
Cloning and domain structure of the mammalian splicing factor U2AF. Nature (1992) 6.55
A multicomponent complex is involved in the splicing of messenger RNA precursors. Cell (1985) 6.27
A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell (1988) 6.16
The "spliceosome": yeast pre-messenger RNA associates with a 40S complex in a splicing-dependent reaction. Science (1985) 5.82
Heterogeneous nuclear ribonucleoproteins: role in RNA splicing. Science (1986) 5.52
Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol Cell Biol (1988) 4.73
A protein that specifically recognizes the 3' splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein. Cell (1986) 4.57
Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes Dev (1989) 4.53
A protein associated with small nuclear ribonucleoprotein particles recognizes the 3' splice site of premessenger RNA. Cell (1986) 4.44
Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev (1991) 4.28
RNA binding specificity of hnRNP proteins: a subset bind to the 3' end of introns. EMBO J (1988) 4.26
An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev (1991) 3.99
The organization of 3' splice-site sequences in mammalian introns. Genes Dev (1989) 3.74
Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev (1993) 3.63
Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes Dev (1991) 3.55
Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol Cell Biol (1993) 3.16
Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev (1992) 3.16
A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83
Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol Cell Biol (1992) 2.66
Role of the 3' splice site consensus sequence in mammalian pre-mRNA splicing. Nature (1985) 2.63
Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of beta-tropomyosin pre-mRNA. J Biol Chem (1992) 2.53
Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev (1991) 2.07
Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol Cell Biol (1994) 2.03
A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J Biol Chem (1993) 2.02
Identification of a functional mammalian spliceosome containing unspliced pre-mRNA. Proc Natl Acad Sci U S A (1988) 1.85
Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs. Nucleic Acids Res (1990) 1.68
The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3' splice site in alternative splicing. EMBO J (1988) 1.66
RNA binding by Sxl proteins in vitro and in vivo. Mol Cell Biol (1994) 1.63
Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res (1994) 1.58
In vitro splicing of mutually exclusive exons from the chicken beta-tropomyosin gene: role of the branch point location and very long pyrimidine stretch. EMBO J (1990) 1.49
Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci U S A (1988) 1.36
In vivo splicing of the beta tropomyosin pre-mRNA: a role for branch point and donor site competition. Mol Cell Biol (1992) 1.24
Alterations in the polypyrimidine sequence affect the in vitro splicing reactions catalyzed by HeLa cell-free preparations. J Biol Chem (1989) 1.11
A 62,000 molecular weight spliceosome protein crosslinks to the intron polypyrimidine tract. Nucleic Acids Res (1990) 1.10
An ATP-independent U2 small nuclear ribonucleoprotein particle/precursor mRNA complex requires both splice sites and the polypyrimidine tract. Proc Natl Acad Sci U S A (1992) 1.03
Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations. Blood (1991) 0.99
A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2. Nucleic Acids Res (1988) 0.91
cis-elements involved in alternative splicing in the rat beta-tropomyosin gene: the 3'-splice site of the skeletal muscle exon 7 is the major site of blockage in nonmuscle cells. Nucleic Acids Res (1993) 0.90
Lariat structures are in vivo intermediates in yeast pre-mRNA splicing. Cell (1984) 8.71
HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (1987) 7.88
Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature (1988) 7.00
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54
The "spliceosome": yeast pre-messenger RNA associates with a 40S complex in a splicing-dependent reaction. Science (1985) 5.82
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Prediction of rho-independent Escherichia coli transcription terminators. A statistical analysis of their RNA stem-loop structures. J Mol Biol (1990) 4.78
HTLV-III in the semen and blood of a healthy homosexual man. Science (1984) 4.53
Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A (1989) 4.21
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. Nature (1993) 3.73
Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res (1991) 3.56
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate. Lancet (1985) 3.50
Pathogenesis of infection with human immunodeficiency virus. N Engl J Med (1987) 3.45
A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell (1998) 3.09
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science (1988) 3.08
Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet (1985) 3.03
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A (1984) 2.86
Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (1993) 2.73
Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res (1989) 2.54
Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature (1992) 2.46
RNA secondary structure repression of a muscle-specific exon in HeLa cell nuclear extracts. Science (1991) 2.45
An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res (1995) 2.44
Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature (1998) 2.36
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1994) 2.24
Report of the Committee on the Genetic Constitution of Chromosomes 20, 21, and 22. Cytogenet Cell Genet (1985) 2.18
Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem (2000) 2.10
Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res (1989) 2.04
International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol (1977) 2.01
Assignment of the human pro alpha 2(I) collagen structural gene (COLIA2) to chromosome 7 by molecular hybridization. Am J Hum Genet (1982) 1.98
A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet (2000) 1.97
Structure of the rat L-type pyruvate kinase gene. J Mol Biol (1987) 1.87
Detection of parasite DNA in Chagas' heart disease. Lancet (1995) 1.86
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A (1985) 1.85
Enzymatic repair of DNA, 1. Purification of two enzymes involved in the excision of thymine dimers from ultraviolet-irradiated DNA. Proc Natl Acad Sci U S A (1969) 1.85
Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia. Neurology (2005) 1.85
The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J (1997) 1.84
Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene. Mol Cell Biol (1990) 1.82
Human type I procollagen genes are located on different chromosomes. Proc Natl Acad Sci U S A (1982) 1.78
The dynamics of caregiving for a demented elder among black and white families. J Gerontol (1992) 1.78
International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol (1979) 1.71
A nuclease that cuts specifically in the ribosome binding site of some T4 mRNAs. Proc Natl Acad Sci U S A (1988) 1.71
Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature (1992) 1.70
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68
A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet (1999) 1.68
Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord (1991) 1.65
The isolation of a human Ig V lambda gene from a recombinant library of chromosome 22 and estimation of its copy number. Nucleic Acids Res (1984) 1.61
MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet (2000) 1.58
Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome: a post-fertilization event. Eur J Hum Genet (1993) 1.57
Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature (1990) 1.54
Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells. Eur J Biochem (1990) 1.52
Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication. J Virol (1996) 1.51
In vitro splicing of mutually exclusive exons from the chicken beta-tropomyosin gene: role of the branch point location and very long pyrimidine stretch. EMBO J (1990) 1.49
Salmonella typhimurium cobalamin (vitamin B12) biosynthetic genes: functional studies in S. typhimurium and Escherichia coli. J Bacteriol (1996) 1.47
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
The Rex system of bacteriophage lambda: tolerance and altruistic cell death. Genes Dev (1992) 1.44
Mutation in RAP1 is a rare event in myelodysplastic syndromes. Leukemia (2005) 1.44
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
Gene dosage effect for human triosephosphate isomerase and glyceraldehyde-3-phosphate dehydrogenase in partial trisomy 12p13 and trisomy 18p. Hum Genet (1978) 1.40
Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations. J Med Genet (2008) 1.31
Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet (1995) 1.30
Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). Brain (1998) 1.30
The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet (1984) 1.30
Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet (1993) 1.27
Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. PCR Methods Appl (1993) 1.24
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain (2005) 1.22
Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation. J Biol Chem (1997) 1.22
Report of the committee on the genetic constitution of chromosomes 20, 21, and 22. Cytogenet Cell Genet (1987) 1.21
Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology (1997) 1.21
cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene. Mol Cell Biol (1992) 1.21
Peripheral selection of V delta 1+ cells with restricted T cell receptor delta gene junctional repertoire in the peripheral blood of healthy donors. J Exp Med (1993) 1.20
Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet (2000) 1.19
Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet (1988) 1.18
Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase B. J Biol Chem (1983) 1.18
Enzymatic repair of DNA. 3. Properties of the UV-endonuclease and UV-exonuclease. Biochemistry (1971) 1.18
Enzymes involved in the early stages of repair of ultraviolet-irradiated DNA. Cold Spring Harb Symp Quant Biol (1968) 1.17
[Gigantism with encephalopathy and craniofacial dysmorphism]. Ann Pediatr (Paris) (1965) 1.17
Lambda Ig constant region genes are translocated to chromosome 8 in Burkitt's lymphoma with t(8;22). Nucleic Acids Res (1983) 1.17
Enzymatic repair of deoxyribonucleic acid. IV. Mechanism of photoproduct excision. Biochemistry (1971) 1.14
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo. Antimicrob Agents Chemother (1993) 1.14
Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci U S A (1992) 1.14
Cell cycle dependence of simian virus 40 induction from transformed hamster cells by ultraviolet irradiation. Virology (1975) 1.12
Electrophoretic study of glutathione reductase in human erythrocytes and leucocytes. Nature (1968) 1.11
Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet (1997) 1.11
A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India. Hum Mol Genet (1996) 1.10
Nucleotide sequence and control of transcription of the bacteriophage T4 motA regulatory gene. Mol Microbiol (1990) 1.09
One gene, but two messenger RNAs encode liver L and red cell L' pyruvate kinase subunits. Nature (1981) 1.09
Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest (1993) 1.09
N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane. Biochem J (1999) 1.08
Excision of viral DNA from host cell DNA after induction of simian virus 40-transformed hamster cells. J Virol (1976) 1.08
SELEX and the evolution of genomes. Curr Opin Genet Dev (1997) 1.08
Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci U S A (1992) 1.07
Identification and biosynthesis of the bacteriophage T4 mot regulatory protein. EMBO J (1983) 1.07